Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Identified a Key Protein in Maintaining the Identity of B Lymphocytes

Published: Monday, June 10, 2013
Last Updated: Monday, June 10, 2013
Bookmark and Share
This finding could be useful for the study of blood diseases such as lymphoma and leukemia.

Researchers of the Epigenetics and Cancer Biology Program at IDIBELL, led by researcher Maribel Parra, have identified a transcriptional repressor, histone deacetylase HDAC7, involved in the identity of B cells, the cells responsible to create antibodies in our immune system.

The results of the study, published in PLoS Genetics, show that HDAC7 is expressed specifically in B lymphocytes and do not in cells of other lineages such as macrophages.

Hematopoietic System

The blood stem cells go through a very complex system of differentiation to form the different blood cells. In the hematopoietic system, there are two main lines: the lymphoid, which results in T cells, B cells and NK cells, among others, and myeloid form erythrocytes (red blood cell) or macrophages among others.

As explained Maribel Parra, to take all the steps of differentiation, there must be changes in cell gene program. There are transcription factors that activate genes in each cell line but it also exist transcriptional repressors that impair the expression of "inappropriate" genes, characteristic of another lineage.

The lab of Maribel Parra studies the role of a family of transcriptional repressor proteins that are in the differentiation of cells of the hematopoietic system. The histone deacetylases (HDAC).
Repression of "inappropriate" genes.

In this work, researchers have shown that the role of HDAC7 protein is to suppress "inappropriate" gens characteristic of other lineages such as macrophages, in B lymphocytes.

Researchers rescheduled B lymphocyte precursor cells into macrophages (myeloid lineage), and found that the expression of HDAC7 decreased dramatically while returning to express this protein inducted blocking of key genes to macrophage biology.

Parra explained that "through this mechanism of transcriptional repression, Cell B ensures that genes characteristics of other cell types are not expressed and maintains its lymphoid identity." He also notes that "given its importance in the biology of B cells, HDAC7 function might be altered in haematological diseases such as leukaemia and lymphomas.  Our research is now going on that direction".


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Patented, a Molecule that Opens the Door to Develop New Drugs Against Immune Rejection
Researchers have patented a peptide that inhibits the immune response activated by the enzyme calcineurin which could serve to develop new more specific immunosuppressive drugs.
Thursday, August 01, 2013
Genetically Modified Stem Cells are Effective Against Acute Respiratory Diseases
Administration of genetically modified mesenchymal stem cells regenerates lung tissue and stops the inflammatory process in mice with acute lung injury.
Tuesday, June 18, 2013
IDIBELL Licenses to Janus a Patent for the Treatment of Immune Diseases
The technology has been developed entirely in the Institute.
Thursday, December 06, 2012
We Need Bacteria to Maintain a Good Immune System
Dr. Francisco Guarner, from the Vall d'Hebron University Hospital, talked about the functions of the bacteria in our body in the IDIBELL Seminar.
Thursday, October 25, 2012
Scientific News
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
New Strategy for Combating Adenoviruses
Using an animal model they developed, Saint Louis University and Utah State university researchers have identified a strategy that could keep a common group of viruses called adenoviruses from replicating and causing sickness in humans.
Major Advance Toward More Effective, Long-Lasting Flu Vaccine
Collaboration shows vaccine candidate can produce powerful ‘broadly neutralizing antibodies’ in animal models.
Immune System: Help for Killer Cells
A study from the University of Bonn may show the way to more effective vaccines.
Protein Found to Control Inflammatory Response
A new Northwestern Medicine study shows that a protein called POP1 prevents severe inflammation and, potentially, diseases caused by excessive inflammatory responses.
A Leap Forward in Vaccinating Against HIV
A team of scientists has developed an experimental vaccine candidate that successfully stimulates the immune system activity in animal models necessary to stop HIV infection.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!